TrianglePUBLICATIONS · 19878872
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Cell
- Publication date
- 2009 Nov 6
- First author
- O'Hare T
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- O'Hare T
- type
- Author
- name
- Shakespeare WC
- type
- Author
- name
- Zhu X
- type
- Author
- name
- Eide CA
- type
- Author
- name
- Rivera VM
- type
- Author
- name
- Wang F
- type
- Author
- name
- Adrian LT
- type
- Author
- name
- Zhou T
- type
- Author
- name
- Huang WS
- type
- Author
- name
- Xu Q
- type
- Author
- name
- Metcalf CA 3rd
- type
- Author
- name
- Tyner JW
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- O'Hare T
- type
- Author
- name
- Shakespeare WC
- type
- Author
- name
- Zhu X
- type
- Author
- name
- Eide CA
- type
- Author
- name
- Rivera VM
- type
- Author
- name
- Wang F
- type
- Author
- name
- Adrian LT
- type
- Author
- name
- Zhou T
- type
- Author
- name
- Huang WS
- type
- Author
- name
- Xu Q
- type
- Author
- name
- Metcalf CA 3rd
- type
- Author
- name
- Tyner JW
- type
- Author
- bibliography ids
- nci-bib-989ab94a40fb631e6e9dfd23
- book metadata
- content sha256
- 83bda05e1092103d67c42adbd4995b59f5bb1e75cc168e1237464748d8ccd002
- document type
- citation
- dois
- 10.1016/j.ccr.2009.09.028
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19878872
- immutable id
- pubmed:19878872@83bda05e1092103d67c42adbd4995b59f5bb1e75cc168e1237464748d8ccd002
- journal
- abbreviation
- Cancer Cell
- issn electronic
- 1878-3686
- issn print
- 1535-6108
- issue
- 5
- name
- Cancer cell
- nlm unique id
- 101130617
- pages
- 401-12
- volume
- 16
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19878872
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- 203fc955ff6055c6dbe1f500f715436d36798874686cbb3e39c353567b2d02f3
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2009 Nov 6
- precision
- day
- year
- 2009
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.
Preserved source evidence · Not medical advice